Stock PEAR PEAR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Pear Therapeutics, Inc.

Equities

PEAR

US7047231052

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 09:30:00 2024-05-22 am EDT 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Pear Therapeutics, Inc. -.--% -.--%
May. 23 Pear Therapeutics, Inc. Went Out of Business CI
May. 08 Combined Liquidation Plan and Disclosure Statement Approved for Pear Therapeutics, Inc. CI

Business Summary

Pear Therapeutics, Inc. is a commercial-stage healthcare company. The Company is engaged in developing a new class of software-based medicines that is referred to as prescription digital therapeutics (PDTs), which use software to treat diseases directly. Its products include reSET and reSET-O. The Company's reSET product is indicated for the treatment of substance use disorder (SUD) as a monotherapy. Its reSET-O product is developed for the treatment of opioid use disorder (OUD) in combination with buprenorphine. The Company’s pipeline consists of product candidates in psychiatry, neurology, and outside-of-central nervous system therapeutic areas. The Company has built a portfolio of PDT product candidates that is primarily focused on psychiatric conditions.

Number of employees: 200

Managers

Managers TitleAgeSince
Christopher Guiffre CEO
 Chief Executive Officer 56 -
Maria Sullivan CTO
 Chief Tech/Sci/R&D Officer - -
Yuri Maricich CTO
 Chief Tech/Sci/R&D Officer 44 -
Ilya Gluhovsky CTO
 Chief Tech/Sci/R&D Officer - -
Corey McCann BRD
 Director/Board Member 45 21-11-30
Meara Murphy IRC
 Investor Relations Contact - -
Beth Keyt LAW
 General Counsel - -
Chris Valosky SAM
 Sales & Marketing - -
Ellen Snow AUD
 Comptroller/Controller/Auditor - -
Anthony L. Watson LAW
 General Counsel 82 -

Members of the board

Members of the board TitleAgeSince
Nancy Schlichting BRD
 Director/Board Member 69 21-11-30
Timothy A. Wicks BRD
 Director/Board Member 58 22-06-13
Corey McCann BRD
 Director/Board Member 45 21-11-30
Alison Bauerlein BRD
 Director/Board Member 42 21-08-31
Shiva Rajaraman BRD
 Director/Board Member 50 22-06-13
Paul Mango BRD
 Director/Board Member - 22-06-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 142,739,169 142,582,029 ( 99.89 %) 0 99.89 %

Company contact information

Pear Therapeutics, Inc.

200 State Street 13th Floor

02109, Boston

+

http://www.peartherapeutics.com
address Pear Therapeutics, Inc.(PEAR)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PEAR THERAPEUTICS, INC. Stock Pear Therapeutics, Inc.
-.--% 142
MODERNA, INC. Stock Moderna, Inc.
+46.45% 54.63B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-6.91% 39.92B
LONZA GROUP AG Stock Lonza Group AG
+37.07% 38.82B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.15% 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
-11.17% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.14% 18.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.93% 12.21B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.45% 12.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+25.36% 11.94B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PEAR Stock
  4. Company Pear Therapeutics, Inc.